Lyell Immunopharma, Inc. - COM (LYEL)

Historical Portfolio Holders from Q2 2021 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
132 M
Holdings value Q1 2024
$295 M
Value change Q1 2024
+$4.21 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
120
Number of buys Q1 2024
57
Number of sells Q1 2024
-55
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
55083R104
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 132 M $295 M +$4.21 M $2.23 120
2023 Q4 128 M $248 M +$952 K $1.94 113
2023 Q3 122 M $180 M +$185 K $1.47 100
2023 Q2 122 M $389 M +$15.2 M $3.18 97
2023 Q1 117 M $277 M +$818 K $2.36 95
2022 Q4 117 M $405 M +$13.8 M $3.47 92
2022 Q3 112 M $823 M +$50.7 M $7.33 86
2022 Q2 106 M $688 M +$42.2 M $6.52 71
2022 Q1 99.5 M $502 M +$55.2 M $5.05 75
2021 Q4 84.5 M $654 M -$25.7 M $7.74 74
2021 Q3 82.5 M $1.22 B +$57.6 M $14.80 61
2021 Q2 78.1 M $1.27 B +$1.27 B $16.24 51